These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
719 related items for PubMed ID: 27088788
1. [Evaluation and treatment of portal hypertension]. Brůha R, Petrtýl J. Cas Lek Cesk; 2016; 155(2):22-6. PubMed ID: 27088788 [Abstract] [Full Text] [Related]
4. Application of a standardised protocol for hepatic venous pressure gradient measurement improves quality of readings and facilitates reduction of variceal bleeding in cirrhotics. Tey TT, Gogna A, Irani FG, Too CW, Lo HG, Tan BS, Tay KH, Lui HF, Chang PE. Singapore Med J; 2016 Mar; 57(3):132-7. PubMed ID: 26996384 [Abstract] [Full Text] [Related]
5. The portal hypertension syndrome: etiology, classification, relevance, and animal models. Bosch J, Iwakiri Y. Hepatol Int; 2018 Feb; 12(Suppl 1):1-10. PubMed ID: 29064029 [Abstract] [Full Text] [Related]
6. Hepatic venous pressure gradient measurement in patients with liver cirrhosis: a correlation with disease severity and variceal bleeding. Silkauskaite V, Pranculis A, Mitraite D, Jonaitis L, Petrenkiene V, Kupcinskas L. Medicina (Kaunas); 2009 Feb; 45(1):8-13. PubMed ID: 19223700 [Abstract] [Full Text] [Related]
7. Hepatic venous pressure gradient and outcomes in cirrhosis. Ripoll C. J Clin Gastroenterol; 2007 Feb; 41 Suppl 3():S330-5. PubMed ID: 17975485 [Abstract] [Full Text] [Related]
8. Pharmacologic prevention of variceal bleeding and rebleeding. Baiges A, Hernández-Gea V, Bosch J. Hepatol Int; 2018 Feb; 12(Suppl 1):68-80. PubMed ID: 29210030 [Abstract] [Full Text] [Related]
9. Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as a guide for prophylaxis and therapy of bleeding and rebleeding? No. Thalheimer U, Bellis L, Puoti C, Burroughs AK. Eur J Intern Med; 2011 Feb; 22(1):5-7. PubMed ID: 21238884 [Abstract] [Full Text] [Related]
11. [Portal pressure should be measured on suspicion of portal hypertension]. Møller S, Bendtsen F. Ugeskr Laeger; 2010 Dec 06; 172(49):3411-3. PubMed ID: 21129318 [Abstract] [Full Text] [Related]
12. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding. Villanueva C, Aracil C, Colomo A, Hernández-Gea V, López-Balaguer JM, Alvarez-Urturi C, Torras X, Balanzó J, Guarner C. Gastroenterology; 2009 Jul 06; 137(1):119-28. PubMed ID: 19344721 [Abstract] [Full Text] [Related]
13. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Moitinho E, Escorsell A, Bandi JC, Salmerón JM, García-Pagán JC, Rodés J, Bosch J. Gastroenterology; 1999 Sep 06; 117(3):626-31. PubMed ID: 10464138 [Abstract] [Full Text] [Related]
14. Preventing first variceal hemorrhage in cirrhosis. Albillos A. J Clin Gastroenterol; 2007 Sep 06; 41 Suppl 3():S305-11. PubMed ID: 17975481 [Abstract] [Full Text] [Related]
15. Three months of simvastatin therapy vs. placebo for severe portal hypertension in cirrhosis: A randomized controlled trial. Pollo-Flores P, Soldan M, Santos UC, Kunz DG, Mattos DE, da Silva AC, Marchiori RC, Rezende GF. Dig Liver Dis; 2015 Nov 06; 47(11):957-63. PubMed ID: 26321186 [Abstract] [Full Text] [Related]
16. Predicting portal hypertension and variceal bleeding using non-invasive measurements of metabolic variables. Eslam M, Ampuero J, Jover M, Abd-Elhalim H, Rincon D, Shatat M, Camacho I, Kamal A, Lo Iacono O, Nasr Z, Grande L, Banares R, Khattab MA, Romero-Gomez M. Ann Hepatol; 2013 Nov 06; 12(4):588-98. PubMed ID: 23813137 [Abstract] [Full Text] [Related]
17. Influence of further decompensation on survival across clinical stages of decompensated cirrhosis: The role of portal hypertension and HVPG changes. Garcia-Guix M, Ardevol A, Sapena V, Alvarado-Tápias E, Huertas A, Brujats A, Fajardo J, Cuyas B, Poca M, Guarner C, Torras X, Escorsell À, Villanueva C. Liver Int; 2024 Aug 06; 44(8):1971-1989. PubMed ID: 38634685 [Abstract] [Full Text] [Related]
18. 5-MTHF enhances the portal pressure reduction achieved with propranolol in patients with cirrhosis: A randomized placebo-controlled trial. Vukotic R, Di Donato R, Roncarati G, Simoni P, Renzulli M, Gitto S, Schepis F, Villa E, Berzigotti A, Bosch J, Andreone P. J Hepatol; 2023 Oct 06; 79(4):977-988. PubMed ID: 37482222 [Abstract] [Full Text] [Related]
19. Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: a clinical-hemodynamic correlation study. La Mura V, Abraldes JG, Berzigotti A, Erice E, Flores-Arroyo A, García-Pagán JC, Bosch J. Hepatology; 2010 Jun 06; 51(6):2108-16. PubMed ID: 20512998 [Abstract] [Full Text] [Related]
20. Recent variceal bleeding: Doppler US hepatic vein waveform in assessment of severity of portal hypertension and vasoactive drug response. Baik SK, Kim JW, Kim HS, Kwon SO, Kim YJ, Park JW, Kim SH, Chang SJ, Lee DK, Han KH, Um SH, Lee SS. Radiology; 2006 Aug 06; 240(2):574-80. PubMed ID: 16864678 [Abstract] [Full Text] [Related] Page: [Next] [New Search]